Recent LIXT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:15:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:15:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:05:55 PM
- Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference • GlobeNewswire Inc. • 04/13/2026 12:00:00 PM
- LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year • GlobeNewswire Inc. • 03/31/2026 07:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 07:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:05:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 08:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:31:36 PM
- LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE • GlobeNewswire Inc. • 01/21/2026 01:00:00 PM
- LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 • GlobeNewswire Inc. • 01/20/2026 01:00:00 PM
- IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. • GlobeNewswire Inc. • 01/13/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 09:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 12:19:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:00:53 PM
- LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial • GlobeNewswire Inc. • 12/23/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2025 10:29:32 PM
- Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/22/2025 09:48:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 11:15:24 AM
- Lixte Biotechnology Shares Dip After $4.3 Million Registered Direct Offering • IH Market News • 12/18/2025 04:00:22 PM
